A metric and workflow for quality control in the analysis of heterogeneity in phenotypic profiles and screens

被引:9
作者
Gough, Albert [1 ,2 ]
Shun, Tong Ying [1 ]
Taylor, D. Lansing [1 ,2 ]
Schurdak, Mark [1 ,2 ]
机构
[1] Univ Pittsburgh, Drug Discovery Inst, 3501 Fifth Ave,BST3 10052, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Dept Computat & Syst Biol, 3501 Fifth Ave, Pittsburgh, PA USA
关键词
Heterogeneity; Phenotypic profiling; High content screening; Systems biology; Drug discovery; KOLMOGOROV-SMIRNOV TEST; TUMOR HETEROGENEITY; CELL VARIABILITY; ORIGINS; BIOLOGY; ERA; MICROENVIRONMENT; ESTABLISHMENT; MICROSCOPY; DISCOVERY;
D O I
10.1016/j.ymeth.2015.10.007
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Heterogeneity is well recognized as a common property of cellular systems that impacts biomedical research and the development of therapeutics and diagnostics. Several studies have shown that analysis of heterogeneity: gives insight into mechanisms of action of perturbagens; can be used to predict optimal combination therapies; and can be applied to tumors where heterogeneity is believed to be associated with adaptation and resistance. Cytometry methods including high content screening (HCS), high throughput microscopy, flow cytometry, mass spec imaging and digital pathology capture cell level data for populations of cells. However it is often assumed that the population response is normally distributed and therefore that the average adequately describes the results. A deeper understanding of the results of the measurements and more effective comparison of perturbagen effects requires analysis that takes into account the distribution of the measurements, i.e. the heterogeneity. However, the reproducibility of heterogeneous data collected on different days, and in different plates/slides has not previously been evaluated. Here we show that conventional assay quality metrics alone are not adequate for quality control of the heterogeneity in the data. To address this need, we demonstrate the use of the KolmogorovSmirnov statistic as a metric for monitoring the reproducibility of heterogeneity in an SAR screen, describe a workflow for quality control in heterogeneity analysis. One major challenge in high throughput biology is the evaluation and interpretation of heterogeneity in thousands of samples, such as compounds in a cell-based screen. In this study we also demonstrate that three heterogeneity indices previously reported, capture the shapes of the distributions and provide a means to filter and browse big data sets of cellular distributions in order to compare and identify distributions of interest. These metrics and methods are presented as a workflow for analysis of heterogeneity in large scale biology projects. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
引用
收藏
页码:12 / 26
页数:15
相关论文
共 39 条
  • [31] The effect of exercise on health-related quality of life in persons with musculoskeletal pain: A meta-analysis of randomised control trials
    Amiri, Sohrab
    [J]. MUSCULOSKELETAL CARE, 2022, 20 (04) : 812 - 820
  • [32] Factors explaining heterogeneity in studies comparing surgical and nonsurgical treatment of midshaft clavicle fractures: a meta-regression analysis of randomized controlled trials and high-quality observational studies
    Reito, Aleksi
    Launonen, Antti
    Paloneva, Juha
    [J]. JOURNAL OF SHOULDER AND ELBOW SURGERY, 2020, 29 (08) : 1726 - 1734
  • [33] Spatial heterogeneity of marginal willingness to pay for air quality in PM2.5: analysis of buyers' housing price in Beijing through hedonic price, spatial regression, and quantile regression models
    Zhang, Chao
    Xiong, Mimi
    Wei, Xuehui
    Lan, Zongmin
    [J]. ASIA-PACIFIC JOURNAL OF REGIONAL SCIENCE, 2023, 7 (03) : 697 - 720
  • [34] Spatial heterogeneity of marginal willingness to pay for air quality in PM2.5: analysis of buyers’ housing price in Beijing through hedonic price, spatial regression, and quantile regression models
    Chao Zhang
    Mimi Xiong
    Xuehui Wei
    Zongmin Lan
    [J]. Asia-Pacific Journal of Regional Science, 2023, 7 : 697 - 720
  • [35] Noninvasive measurement of cell/colony motion using image analysis methods to evaluate the proliferative capacity of oral keratinocytes as a tool for quality control in regenerative medicine
    Hoshikawa, Emi
    Sato, Taisuke
    Kimori, Yoshitaka
    Suzuki, Ayako
    Haga, Kenta
    Kato, Hiroko
    Tabeta, Koichi
    Nanba, Daisuke
    Izumi, Kenji
    [J]. JOURNAL OF TISSUE ENGINEERING, 2019, 10
  • [36] Multicapillary SDS-gel electrophoresis for the analysis of fluorescently labeled mAb preparations: A high throughput quality control process for the production of QuantiPlasma and PlasmaScan mAb libraries
    Szekely, Andrea
    Szekrenyes, Akos
    Kerekgyarto, Marta
    Balogh, Attila
    Kadas, Janos
    Lazar, Jozsef
    Guttman, Andras
    Kurucz, Istvan
    Takacs, Laszlo
    [J]. ELECTROPHORESIS, 2014, 35 (15) : 2155 - 2162
  • [37] PRODUCTION OF A PRELIMINARY QUALITY CONTROL PIPELINE FOR SINGLE NUCLEI RNA-SEQ AND ITS APPLICATION IN THE ANALYSIS OF CELL TYPE DIVERSITY OF POST-MORTEM HUMAN BRAIN NEOCORTEX
    Aevermann, Brian
    Mccorrison, Jamison
    Venepally, Pratap
    Hodge, Rebecca
    Bakken, Trygve
    Miller, Jeremy
    Novotny, Mark
    Tran, Danny N.
    Diez-Fuertes, Francisco
    Christiansen, Lena
    Zhang, Fan
    Steemers, Frank
    Lasken, Roger S.
    Lein, Ed
    Schork, Nicholas
    Scheuermann, Richard H.
    [J]. PACIFIC SYMPOSIUM ON BIOCOMPUTING 2017, 2017, : 564 - 575
  • [38] Effects of pharmacist-led interventions on glycaemic control, adherence, disease management and health-related quality of life in patients with type 2 diabetes: a protocol for a network meta-analysis
    Weng, Yiqing
    Miao, Binghui
    Hong, Dongsheng
    Zhang, Mengdie
    Wang, Beijia
    Zhao, Qingwei
    Wang, Hongmei
    [J]. BMJ OPEN, 2023, 13 (10):
  • [39] The effects of glucagon-like peptide-1 receptor agonists on glycemic control and anthropometric profiles among diabetic patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials
    Nowrouzi-Sohrabi, Peyman
    Rezaei, Shahla
    Jalali, Mohammad
    Ashourpour, Mahkameh
    Ahmadipour, Ahmad
    Keshavarz, Pedram
    Akbari, Hamed
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 893